ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Pharmarise Holdings Corp. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 3.11% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Poor long term growth as Net Sales has grown by an annual rate of 3.11% over the last 5 years
3
The company has declared Negative results for the last 5 consecutive quarters
- NET PROFIT(9M) At JPY -334.83 MM has Grown at -8,084.63%
- INTEREST(HY) At JPY 123 MM has Grown at 80.88%
- DEBT-EQUITY RATIO (HY) Highest at 144.04 %
4
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 6.24%, its profits have fallen by -135.8%
5
Underperformed the market in the last 1 year
- The stock has generated a return of 6.24% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 38.30%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Pharmarise Holdings Corp. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Pharmarise Holdings Corp.
6.24%
-1.29
15.65%
Japan Nikkei 225
40.96%
1.35
28.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.11%
EBIT Growth (5y)
-33.14%
EBIT to Interest (avg)
16.35
Debt to EBITDA (avg)
2.65
Net Debt to Equity (avg)
1.73
Sales to Capital Employed (avg)
3.13
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.02%
ROE (avg)
5.48%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.83
EV to EBIT
118.54
EV to EBITDA
11.57
EV to Capital Employed
0.94
EV to Sales
0.29
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.79%
ROE (Latest)
-2.20%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend17What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -0.87% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 18.69 times
OPERATING PROFIT(Q)
Highest at JPY 636 MM
OPERATING PROFIT MARGIN(Q)
Highest at 3.77 %
PRE-TAX PROFIT(Q)
Highest at JPY 192 MM
NET PROFIT(Q)
Highest at JPY 104.51 MM
EPS(Q)
Highest at JPY 10.93
-16What is not working for the Company
NET PROFIT(9M)
At JPY -334.83 MM has Grown at -8,084.63%
INTEREST(HY)
At JPY 123 MM has Grown at 80.88%
DEBT-EQUITY RATIO
(HY)
Highest at 144.04 %
CASH AND EQV(HY)
Lowest at JPY 4,679 MM
INVENTORY TURNOVER RATIO(HY)
Lowest at 14.42 times
Here's what is working for Pharmarise Holdings Corp.
Pre-Tax Profit
At JPY 192 MM has Grown at 214.75%
over average net sales of the previous four periods of JPY 61 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (JPY MM)
Net Profit
At JPY 104.51 MM has Grown at 173.3%
over average net sales of the previous four periods of JPY -142.58 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (JPY MM)
Operating Profit
Highest at JPY 636 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (JPY MM)
Operating Profit Margin
Highest at 3.77 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at JPY 192 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (JPY MM)
Net Profit
Highest at JPY 104.51 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (JPY MM)
EPS
Highest at JPY 10.93
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (JPY)
Debtors Turnover Ratio
Highest at 18.69 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -0.87% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Pharmarise Holdings Corp.
Interest
At JPY 123 MM has Grown at 80.88%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Debt-Equity Ratio
Highest at 144.04 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Cash and Eqv
Lowest at JPY 4,679 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Inventory Turnover Ratio
Lowest at 14.42 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
